Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDDK

A3 Adenosine Receptor Allosteric Modulators

  • Read more about A3 Adenosine Receptor Allosteric Modulators
US Application 60/762,141
Filed on 2006-01-26

Prodrug Delivery Of A3 Adenosine Receptor Antagonists For Glaucoma Therapy

  • Read more about Prodrug Delivery Of A3 Adenosine Receptor Antagonists For Glaucoma Therapy
US Application 60/718,642
Filed on 2005-09-20

Methods for Producing and Using Pancreatic Endocrine Cells

  • Read more about Methods for Producing and Using Pancreatic Endocrine Cells
US Application 60/752,822
Filed on 2005-12-21

Genomic Nucleic Acid Sequence for Cyanovirin-N and Signal Peptide Thereof

  • Read more about Genomic Nucleic Acid Sequence for Cyanovirin-N and Signal Peptide Thereof
US Application 60/696,599
Filed on 2005-07-05

System and methods for detecting and characterizing macromolecular interactions in solution

  • Read more about System and methods for detecting and characterizing macromolecular interactions in solution
US Application 60/703,814
Filed on 2005-07-28

Automated Non-Invasive Real-Time ARF Detection System And Method Using Modified Raman Technology

  • Read more about Automated Non-Invasive Real-Time ARF Detection System And Method Using Modified Raman Technology
US Application 60/564,744
Filed on 2005-04-22

Process For The Synthesis Of Anticonvulsive Agents Of 2-carboxyquinoline Derivatives3

  • Read more about Process For The Synthesis Of Anticonvulsive Agents Of 2-carboxyquinoline Derivatives3
US Application 60/689,809
Filed on 2005-06-13

In Vitro Model For Hepatitis C Virion Production

  • Read more about In Vitro Model For Hepatitis C Virion Production
US Application 60/615,301
Filed on 2004-09-30

(N)-Methanocarba Adenosine Derivatives As A3 Receptor Agonists

  • Read more about (N)-Methanocarba Adenosine Derivatives As A3 Receptor Agonists
US Application 60/608,823
Filed on 2004-09-09

Identification Of Immunogenic T Cell Targets Within SLA And Cytochrome P450 2D6, The Autoantigens In Autoimmune Hepatitis Type 3 And Type 2

  • Read more about Identification Of Immunogenic T Cell Targets Within SLA And Cytochrome P450 2D6, The Autoantigens In Autoimmune Hepatitis Type 3 And Type 2
US Application 60/659,513
Filed on 2005-03-07

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDDK
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health